Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive

Servicio de Neurología, Hospital Clínico San Carlos, Madrid 28040, Spain

^* To whom correspondence should be addressed.

	Abstract

Recently, it has been suggested that human herpesvirus-6 (HHV-6) may play a role in the pathogenesis of relapsing-remitting multiple sclerosis (RRMS), but there is not enough information related to the role of HHV-6 in secondary-progressive MS (SPMS). To address this question, we evaluated HHV-6 prevalence, active viral replication and viral load measured by quantitative real-time PCR, in DNA and mRNA extracted from peripheral blood mononuclear cells (PBMCs) and DNA extracted from serum; the samples were collected from 31 SPMS and 31 RRMS patients in a one-year follow-up study, and sex- and age-matched controls. The results were as follows: i) We found a statistical significant difference in HHV-6 DNA prevalences between RRMS and SPMS patients in: DNA extracted from PBMCs (P=0.027), DNA extracted from serum (P=0.010) and mRNA extracted from PBMCs (P=0.010). When we compared HHV-6 prevalences from RRMS patients in relapse and in remission with those from SPMS patients, we only achieved a statistical significance for the relapses (P=0.003 in DNA from PBMCs, and P<0.001 in DNA from serum samples and mRNA from PBMCs). ii) We only found HHV-6 variant A among HHV-6 positive samples in serum. iii) We did not find any difference in HHV-6 viral loads. These results suggest that HHV-6A does not play an active role in SPMS, while this virus may contribute to the pathogenesis of RRMS triggering MS attacks in a subset of patients.

Key Words: HHV-6, multiple sclerosis, PCR, relapsing-remitting, secondary progressive

First published on February 16, 2007, doi:10.1177/1352458506072667

Multiple Sclerosis 2007;13:578.

A more recent version of this article appeared on June 1, 2007


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R Alvarez-Lafuente, M Garcia-Montojo, V De Las Heras, M. Dominguez-Mozo, M Bartolome, M. Benito-Martin, and R Arroyo Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients Multiple Sclerosis, June 1, 2008; 14(5): 595 - 601. [Abstract] [PDF]

				M. Ghei, J. D. Fett, V. Descamps, P. Joly, P. Musette, M. A. Mir, F. Khalil, M. S. Sabatine, J. L. Mega, and J. R. Stone Case 36-2007: a woman with rash, fever, and hypotension. N. Engl. J. Med., March 27, 2008; 358(13): 1405 - 1406. [Full Text] [PDF]

				G. Mlechkovich and N. Frenkel Human Herpesvirus 6A (HHV-6A) and HHV-6B Alter E2F1/Rb Pathways and E2F1 Localization and Cause Cell Cycle Arrest in Infected T Cells J. Virol., December 15, 2007; 81(24): 13499 - 13508. [Abstract] [Full Text] [PDF]

				J. G. Millichap Multinational Study of Childhood Multiple Sclerosis: Risk Factors and Outcome AAP Grand Rounds, November 1, 2007; 18(5): 58 - 58. [Full Text] [PDF]